Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
-
- Hirotoshi Watanabe
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
-
- Takenori Domei
- Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu, Japan
-
- Takeshi Morimoto
- Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan
-
- Masahiro Natsuaki
- Department of Cardiovascular Medicine, Saga University, Saga, Japan
-
- Hiroki Shiomi
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
-
- Toshiaki Toyota
- Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
-
- Masanobu Ohya
- Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan
-
- Satoru Suwa
- Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan
-
- Kensuke Takagi
- Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan
-
- Mamoru Nanasato
- Department of Cardiology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
-
- Yoshiki Hata
- Department of Cardiology, Minamino Cardiovascular Hospital, Hachioji, Japan
-
- Masahiro Yagi
- Department of Cardiology, Sendai Cardiovascular Center, Sendai, Japan
-
- Nobuhiro Suematsu
- Department of Cardiology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
-
- Takafumi Yokomatsu
- Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan
-
- Itaru Takamisawa
- Department of Cardiology, Sakakibara Heart Institute, Fuchu, Japan
-
- Masayuki Doi
- Department of Cardiology, Kagawa Prefectural Central Hospital, Takamatsu, Japan
-
- Toshiyuki Noda
- Department of Cardiology, Gifu Prefectural General Medical Center, Gifu, Japan
-
- Hideki Okayama
- Department of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan
-
- Yoshitane Seino
- Department of Cardiology, Hoshi General Hospital, Koriyama, Japan
-
- Tomohisa Tada
- Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan
-
- Hiroki Sakamoto
- Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan
-
- Kiyoshi Hibi
- Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan
-
- Mitsuru Abe
- Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
-
- Kazuya Kawai
- Department of Cardiology, Chikamori Hospital, Kochi, Japan
-
- Koichi Nakao
- Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan
-
- Kenji Ando
- Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu, Japan
-
- Kengo Tanabe
- Department of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
-
- Yuji Ikari
- Department of Cardiology, Tokai University Hospital, Isehara, Japan
-
- Keiichi Igarashi Hanaoka
- Hanaoka Seishu Memorial Cardiovascular Clinic, Sapporo, Japan
-
- Yoshihiro Morino
- Department of Cardiology, Iwate Medical University Hospital, Morioka, Japan
-
- Ken Kozuma
- Department of Cardiology, Teikyo University Hospital, Tokyo, Japan
-
- Kazushige Kadota
- Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan
-
- Yutaka Furukawa
- Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
-
- Yoshihisa Nakagawa
- Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan
-
- Takeshi Kimura
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
書誌事項
- タイトル別名
-
- The STOPDAPT-2 Randomized Clinical Trial
収録刊行物
-
- JAMA
-
JAMA 321 (24), 2414-, 2019-06-25
American Medical Association (AMA)
